Company Profile:
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING & BIOTECH is neither a factory nor a trading company. It is a world-renowned intergovernmental organization dedicated to research and training.
Company Introduction:
The International Centre for Genetic Engineering and Biotechnology (ICGEB) is an intergovernmental organization established to promote international cooperation in biotechnology for the benefit of developing countries. While its headquarters are in Trieste, Italy, it maintains significant components in New Delhi, India, and Cape Town, South Africa.
The Indian component of ICGEB, located in New Delhi, is a leading research institute focusing on cutting-edge research and development in various fields of biotechnology. Its primary mission is to conduct advanced research, provide scientific training, and facilitate technology transfer in areas vital to human health, agriculture, and industrial biotechnology.
Key areas of research at ICGEB New Delhi include infectious diseases (such as malaria, dengue, chikungunya, and tuberculosis), plant biotechnology, structural biology, immunology, and vaccine development. The center is actively involved in developing innovative solutions to global challenges, particularly those affecting developing nations. It offers PhD programs and postdoctoral fellowships, fostering the next generation of scientists and promoting scientific capacity building. Through its extensive network and collaborative projects, ICGEB aims to translate scientific discoveries into tangible benefits for society.
Enterprise Products
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING & BIOTECH (ICGEB), India, primarily focuses on research and training rather than direct production and sale of products. However, technologies developed at ICGEB may be licensed to other companies for commercialization.
Their research areas include:
* **Human Health:** Development of diagnostics, vaccines, and therapeutics for diseases like malaria, dengue, and HIV.
* **Agriculture:** Development of improved crop varieties with enhanced yield, pest resistance, and stress tolerance.
* **Biotechnology:** Development of industrial enzymes, biofuels, and bioremediation technologies.
Therefore, ICGEB itself does not typically "sell" products in the traditional sense. But, potential products resulting from their research that might be commercialized by partner companies could include:
* Diagnostic kits for infectious diseases
* Recombinant vaccines
* Genetically modified seeds
* Industrial enzymes